Quest Partners LLC Increases Position in U.S. Physical Therapy, Inc. (NYSE:USPH) (2025)

Quest Partners LLC increased its position in U.S. Physical Therapy, Inc. (NYSE:USPH - Free Report) by 2,368.2% in the 3rd quarter, according to the company in its most recent filing with the SEC. The fund owned 8,614 shares of the company's stock after acquiring an additional 8,265 shares during the quarter. Quest Partners LLC owned about 0.06% of U.S. Physical Therapy worth $729,000 as of its most recent SEC filing.

Other large investors also recently added to or reduced their stakes in the company. Canada Pension Plan Investment Board purchased a new position in U.S. Physical Therapy during the 2nd quarter valued at about $28,000. Innealta Capital LLC bought a new stake in shares of U.S. Physical Therapy during the 2nd quarter valued at about $30,000. Quarry LP boosted its position in shares of U.S. Physical Therapy by 1,291.9% during the 2nd quarter. Quarry LP now owns 515 shares of the company's stock valued at $48,000 after acquiring an additional 478 shares during the last quarter. Ridgewood Investments LLC bought a new stake in shares of U.S. Physical Therapy during the 2nd quarter valued at about $51,000. Finally, KBC Group NV lifted its position in U.S. Physical Therapy by 68.6% in the 3rd quarter. KBC Group NV now owns 774 shares of the company's stock worth $66,000 after buying an additional 315 shares during the last quarter.

Insider Buying and Selling

In other news, Director Bernard A. Harris, Jr. sold 2,000 shares of the firm's stock in a transaction that occurred on Tuesday, November 12th. The stock was sold at an average price of $92.95, for a total value of $185,900.00. Following the completion of the sale, the director now directly owns 16,726 shares of the company's stock, valued at $1,554,681.70. This trade represents a 10.68 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, COO Graham D. Reeve sold 1,724 shares of the firm's stock in a transaction that occurred on Friday, November 8th. The stock was sold at an average price of $96.29, for a total value of $166,003.96. Following the sale, the chief operating officer now directly owns 7,106 shares of the company's stock, valued at $684,236.74. This represents a 19.52 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 6,896 shares of company stock worth $656,940. 1.70% of the stock is owned by corporate insiders.

U.S. Physical Therapy Stock Performance

USPH stock traded up $0.89 during trading on Friday, reaching $97.83. The stock had a trading volume of 179,158 shares, compared to its average volume of 93,323. U.S. Physical Therapy, Inc. has a 52 week low of $76.18 and a 52 week high of $113.63. The stock's 50 day moving average is $84.95 and its two-hundred day moving average is $90.89. The company has a current ratio of 1.78, a quick ratio of 1.78 and a debt-to-equity ratio of 0.27. The firm has a market cap of $1.48 billion, a PE ratio of 104.32, a PEG ratio of 4.10 and a beta of 1.38.

U.S. Physical Therapy Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, December 6th. Investors of record on Friday, November 15th will be given a dividend of $0.44 per share. This represents a $1.76 annualized dividend and a dividend yield of 1.80%. The ex-dividend date of this dividend is Friday, November 15th. U.S. Physical Therapy's dividend payout ratio is currently 187.23%.

Wall Street Analyst Weigh In

A number of equities analysts have commented on the company. Bank of America reaffirmed a "neutral" rating and issued a $90.00 price target (down from $114.00) on shares of U.S. Physical Therapy in a research note on Monday, October 7th. StockNews.com raised U.S. Physical Therapy from a "sell" rating to a "hold" rating in a research note on Wednesday, August 21st. Finally, Barrington Research reaffirmed an "outperform" rating and issued a $108.00 price target on shares of U.S. Physical Therapy in a research note on Thursday.

Get Our Latest Stock Report on U.S. Physical Therapy

U.S. Physical Therapy Company Profile

(Free Report)

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.

Read More

• Five stocks we like better than U.S. Physical Therapy
• What is a Secondary Public Offering? What Investors Need to Know
• Tesla Investors Continue to Profit From the Trump Trade
• What is the Dogs of the Dow Strategy? Overview and Examples
• MicroStrategy’s Stock Dip vs. Coinbase’s Potential Rally
• Stocks with Unusual Volume: How to Find Unusual Volume Stocks in Real Time
• Netflix Ventures Into Live Sports, Driving Stock Momentum

Should you invest $1,000 in U.S. Physical Therapy right now?

Before you consider U.S. Physical Therapy, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and U.S. Physical Therapy wasn't on the list.

While U.S. Physical Therapy currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here